Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/dmrr.3379 http://scihub22266oqcxt.onion/10.1002/dmrr.3379 32592507!7362015!32592507     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Diabetes+Metab+Res+Rev 2021 ; 37 (2): e3379 Nephropedia Template TP {{tp|p=32592507|t=2021. Hydroxychloroquine, COVID-19 and diabetes Why it is a different story |pdf=|usr=}}{{32592507}} gab.com Text Hydroxychloroquine, COVID-19 and diabetes Why it is a different story JO: Diabetes Metab Res Rev http://www.kidney.de/pget.php?&tw=1&pmid=32592507 #FOAvip Hydroxychloroquine has been proposed for the cure of the COVID-19 due to its anti-inflammatory and anti-viral action. People with diabetes are more prone to severe outcome if affected by COVID-19 and the use of Hydroxychloroquine might have some benefit in this setting. However, the use of Hydroxychloroquine in diabetes deserves particular attention for its documented hypoglycemic action. Twit Text FOAVip Hydroxychloroquine, COVID-19 and diabetes Why it is a different story ????Diabetes Metab Res Rev http://www.kidney.de/pget.php?&tw=1&pmid=32592507 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32592507 #FOAvip English Wikipedia <ref>{{Cite pmid|32592507}}</ref> Hydroxychloroquine, COVID-19 and diabetes Why it is a different story #MMPMID32592507 Stoian AP; Catrinoiu D; Rizzo M; Ceriello A Diabetes Metab Res Rev 2021[Feb]; 37 (2): e3379 PMID32592507show ga Hydroxychloroquine has been proposed for the cure of the COVID-19 due to its anti-inflammatory and anti-viral action. People with diabetes are more prone to severe outcome if affected by COVID-19 and the use of Hydroxychloroquine might have some benefit in this setting. However, the use of Hydroxychloroquine in diabetes deserves particular attention for its documented hypoglycemic action. |*COVID-19 Drug Treatment[MESH] |Blood Glucose/*drug effects/metabolism[MESH] |COVID-19/blood/epidemiology/pathology[MESH] |Diabetes Complications/drug therapy/epidemiology[MESH] |Diabetes Mellitus/blood/*drug therapy/epidemiology[MESH] |Glycemic Control/methods[MESH] |Humans[MESH] |Hydroxychloroquine/*therapeutic use[MESH] |Hypoglycemic Agents/therapeutic use[MESH] |SARS-CoV-2/drug effects[MESH] |Severity of Illness Index[MESH]Hydroxychloroquine, COVID-19 and diabetes Why it is a different story(epmc).pdf DeepDyve Pubget Overpricing